Budesonide ER Capsules
Closed Solicitation Posted
- Solicitation number
- SPE2D2-25-R-0008
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency Troop Support Medical issued Solicitation SPE2D225R0008 for Budesonide ER 3MG Capsules to support the Department of Defense, Department of Veterans Affairs, Bureau of Prisons, and Indian Health Service through Pharmaceutical Prime Vendor programs. The procurement seeks a national contract to supply 29,716 100-count bottles of Budesonide ER 3MG Capsules annually, with offerors required to comply with FDA regulations, submit subcontracting plans if applicable, meet product registration and packaging specifications, and adhere to therapeutic equivalence standards. The acquisition strategy follows a lowest price technically acceptable evaluation criteria, with offers originally due April 30, 2025, later extended to May 14, 2025. Contractors must provide quarterly sales reports, pay a 0.5% cost recovery fee, and maintain FDA current Good Manufacturing Practice standards to ensure uninterrupted supply. However, the entire solicitation was subsequently canceled via Amendment 0002, effective July 31, 2025.
This procurement opportunity carried no set-aside designation and was open to all qualified offerors in the pharmaceutical preparation manufacturing sector. The contract structure included a one-year base period with four option years, creating a potential maximum five-year performance period for the successful contractor. The annual requirement of 29,716 100-count bottles represents a significant pharmaceutical supply commitment across multiple federal agencies and programs. Successful contractors would have been required to establish business-to-business agreements with current Pharmaceutical Prime Vendor contractors to fulfill distribution requirements. The solicitation ultimately became moot due to the complete cancellation issued in the final amendment, preventing any award from being made under this particular procurement action.
Notice text
SPE2D225R0008 Budesonide ER Capsules Solicitation
Files
| File | Type | Posted |
|---|---|---|
| SPE2D225R00080002 released.pdf | ||
| SPE2D225R00080001 released.pdf | ||
| Budesonide ER SPE2D225R0008 Solicitation.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Solicitation | |
| Budesonide ER Capsules | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Methylphenidate ER | Medical Supply Chain | No set-aside | |
| 6505--Imatinib Tablets | National Acquisition Center | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity